Nutrien (NYSE:NTR) Given New $53.00 Price Target at UBS Group

Nutrien (NYSE:NTRGet Free Report) had its price target raised by research analysts at UBS Group from $51.00 to $53.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s target price points to a potential upside of 1.12% from the company’s current price.

A number of other research analysts also recently weighed in on the company. TD Securities cut their price objective on Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a research note on Tuesday, November 12th. Raymond James upgraded Nutrien from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $58.00 to $60.00 in a report on Tuesday, December 3rd. Barclays reiterated an “equal weight” rating and set a $56.00 price target (up from $55.00) on shares of Nutrien in a report on Tuesday, January 21st. Oppenheimer assumed coverage on Nutrien in a report on Thursday, December 12th. They set an “outperform” rating and a $60.00 price target for the company. Finally, CIBC reiterated an “outperformer” rating and set a $55.00 price target (down from $60.00) on shares of Nutrien in a report on Tuesday, December 10th. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $58.94.

Read Our Latest Analysis on Nutrien

Nutrien Stock Down 0.2 %

Shares of Nutrien stock opened at $52.42 on Tuesday. The stock has a 50-day simple moving average of $47.61 and a 200-day simple moving average of $47.98. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. Nutrien has a 52-week low of $43.69 and a 52-week high of $60.87. The firm has a market cap of $25.74 billion, a price-to-earnings ratio of 35.33, a P/E/G ratio of 1.17 and a beta of 0.81.

Nutrien (NYSE:NTRGet Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The company had revenue of $5.35 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same period in the previous year, the business posted $0.35 earnings per share. The firm’s revenue was down 5.0% on a year-over-year basis. On average, equities research analysts expect that Nutrien will post 3.5 earnings per share for the current fiscal year.

Institutional Trading of Nutrien

A number of large investors have recently bought and sold shares of NTR. Silchester International Investors LLP grew its holdings in shares of Nutrien by 9.5% during the fourth quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company’s stock worth $523,268,000 after purchasing an additional 1,009,895 shares during the last quarter. ARGA Investment Management LP grew its holdings in shares of Nutrien by 25.7% during the fourth quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company’s stock worth $270,396,000 after purchasing an additional 1,236,671 shares during the last quarter. National Bank of Canada FI grew its holdings in shares of Nutrien by 4.1% during the third quarter. National Bank of Canada FI now owns 4,232,211 shares of the company’s stock worth $203,380,000 after purchasing an additional 165,582 shares during the last quarter. Toronto Dominion Bank boosted its holdings in Nutrien by 11.9% in the third quarter. Toronto Dominion Bank now owns 4,220,354 shares of the company’s stock valued at $202,830,000 after acquiring an additional 447,413 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new position in Nutrien in the third quarter valued at about $150,181,000. 63.10% of the stock is currently owned by institutional investors.

About Nutrien

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Read More

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.